Michael Barbella, Managing Editor09.07.23
Rockwell Medical Inc. has entered into a three-year co-promotion services agreement with B. Braun Medical Inc.
As part of the agreement, Rockwell Medical designates B. Braun as an independent, non-exclusive representative to promote the company's hemodialysis concentrates products to U.S. dialysis providers, concertedly on the west coast. All terms of the sale of any Rockwell Medical product, including price, delivery schedule, and terms and conditions, are set by Rockwell Medical, at the company's sole discretion. All orders will be directed to, and processed by, Rockwell Medical. B. Braun will receive a fee for any sales generated by its promotional efforts.
"This co-marketing and sales arrangement with B. Braun represents a significant commercial opportunity for Rockwell Medical that immediately connects us to a new customer base we wouldn't be able to reach otherwise," said Tim Chole, senior vice president, Sales and Marketing, at Rockwell Medical. "We are excited to collaborate with B. Braun to augment our commercial efforts. B. Braun’s national sales organization will enable us to generate new business leads and integrate our hemodialysis concentrates products into B. Braun's robust portfolio of renal care products. Now, B. Braun's sales team will be able to introduce Rockwell Medical's complementary products to new customers as part of a complete portfolio, ultimately providing a positive impact on the lives of more hemodialysis patients."
“We are pleased to align with Rockwell Medical to promote their hemodialysis concentrate products,” said Jonathan Stapley, senior director of Marketing, Active Devices, at B. Braun. “This ensures we can supply our providers and the patients they serve with a broader range of hemodialysis products.”
B. Braun Medical Inc. is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. B. Braun is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the United States, which includes B. Braun Interventional Systems, Aesculap, and CAPS. The company employs 8,500 people at more than 30 locations across North America. Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries.
Rockwell Medical Inc. develops, manufactures, commercializes, and distributes hemodialysis products for dialysis providers worldwide. Hemodialysis is the most common form of end-stage kidney disease treatment and is usually performed at freestanding outpatient dialysis centers, at hospital-based outpatient centers, at skilled nursing facilities, or in a patient’s home. Rockwell Medical is the second largest supplier of acid and bicarbonate concentrates for dialysis patients in the United States.
As part of the agreement, Rockwell Medical designates B. Braun as an independent, non-exclusive representative to promote the company's hemodialysis concentrates products to U.S. dialysis providers, concertedly on the west coast. All terms of the sale of any Rockwell Medical product, including price, delivery schedule, and terms and conditions, are set by Rockwell Medical, at the company's sole discretion. All orders will be directed to, and processed by, Rockwell Medical. B. Braun will receive a fee for any sales generated by its promotional efforts.
"This co-marketing and sales arrangement with B. Braun represents a significant commercial opportunity for Rockwell Medical that immediately connects us to a new customer base we wouldn't be able to reach otherwise," said Tim Chole, senior vice president, Sales and Marketing, at Rockwell Medical. "We are excited to collaborate with B. Braun to augment our commercial efforts. B. Braun’s national sales organization will enable us to generate new business leads and integrate our hemodialysis concentrates products into B. Braun's robust portfolio of renal care products. Now, B. Braun's sales team will be able to introduce Rockwell Medical's complementary products to new customers as part of a complete portfolio, ultimately providing a positive impact on the lives of more hemodialysis patients."
“We are pleased to align with Rockwell Medical to promote their hemodialysis concentrate products,” said Jonathan Stapley, senior director of Marketing, Active Devices, at B. Braun. “This ensures we can supply our providers and the patients they serve with a broader range of hemodialysis products.”
B. Braun Medical Inc. is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. B. Braun is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the United States, which includes B. Braun Interventional Systems, Aesculap, and CAPS. The company employs 8,500 people at more than 30 locations across North America. Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries.
Rockwell Medical Inc. develops, manufactures, commercializes, and distributes hemodialysis products for dialysis providers worldwide. Hemodialysis is the most common form of end-stage kidney disease treatment and is usually performed at freestanding outpatient dialysis centers, at hospital-based outpatient centers, at skilled nursing facilities, or in a patient’s home. Rockwell Medical is the second largest supplier of acid and bicarbonate concentrates for dialysis patients in the United States.